Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




New Benchtop Cross-Flow Filtration System Suits Research and Production Labs

By LabMedica International staff writers
Posted on 02 Feb 2016
An advanced cross-flow filtration system is now available for biotechnology and other life sciences research and production laboratories.

Sartorius Stedim Biotech (Gottingen, Germany) has announced the launch of the SARTOFLOW Smart benchtop, cross-flow ultrafiltration and diafiltration system. More...


The SARTOFLOW Smart is a modular and flexible small scale benchtop cross-flow system optimized for ultrafiltration and diafiltration applications used in many downstream processes, such as purification of vaccines, monoclonal antibodies, and recombinant proteins. The system is suitable for use in research laboratories and in laboratory environments for process development and clinical trials as well as for cGMP production environments.

The SARTOFLOW Smart system includes a Sartocon Slice 200 filter cassette holder that can accommodate cassette areas from 200 square centimeters to 0.14 square meters membrane area; one liter graduated recirculation vessel made of transparent PSU with a self-sealing lid; and a vortex breaker with magnetic stir bar for effective mixing.

The tank is located on top of a load cell for level control. The systems includes three pressure sensors, one each in the feed, retentate, and permeate lines for operating the system at user-defined set points. Interactive prompts for easy guidance through entire control sequences are displayed conveniently on a seven inch touch screen.

One peristaltic diafiltration pump is available, an option that enables loading product or buffer as a discrete process step. An electronic balance is an integral component of the system for monitoring the quantitative collection of filtrate and its collection rate. A low shear four-piston membrane pump provides a wide range of flow rates making it possible to use a wide variety of membrane areas.

“SARTOFLOW Smart is a milestone development in the landscape of small cross-flow systems. It combines outstanding technology with options that are normally only available with process systems. With an exceptionally wide working range of membrane surface areas, the system is the perfect tool for both R&D optimization trials and cGMP production,” said Dr. Marc Jenke, expert for benchtop cross-flow filtration systems at Sartorius Stedim Biotech.

Related Links:

Sartorius Stedim Biotech



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Procalcitonin Test
LIAISON B•R•A•H•M•S PCT II GEN
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.